Search

Your search keyword '"Cheung, Ramsey C."' showing total 254 results
Start Over Author "Cheung, Ramsey C."
254 results on '"Cheung, Ramsey C."'

8. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040

Author

Ito, Takanori, Ishigami, Masatoshi, Zou, Biyao, Tanaka, Taku, Takahashi, Hirokazu, Kurosaki, Masayuki, Maeda, Mayumi, Thin, Khin Naing, Tanaka, Kenichi, Takahashi, Yuka, Itoh, Yoshito, Oniki, Kentaro, Seko, Yuya, Saruwatari, Junji, Kawanaka, Miwa, Atsukawa, Masanori, Hyogo, Hideyuki, Ono, Masafumi, Ogawa, Eiichi, Barnett, Scott D., Stave, Christopher D., Cheung, Ramsey C., Fujishiro, Mitsuhiro, Eguchi, Yuichiro, Toyoda, Hidenori, and Nguyen, Mindie H.

Published
2021
Full Text
View/download PDF

10. Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

Author

Ji, Fanpu, Yeo, Yee Hui, Wei, Mike Tzuhen, Ogawa, Eiichi, Enomoto, Masaru, Lee, Dong Hyun, Iio, Etsuko, Lubel, John, Wang, Wenjun, Wei, Bin, Ide, Tatsuya, Preda, Carmen Monica, Conti, Fabio, Minami, Tatsuya, Bielen, Rob, Sezaki, Hitomi, Barone, Michele, Kolly, Philippe, Chu, Po-sung, Virlogeux, Victor, Eurich, Dennis, Henry, Linda, Bass, Michelle B., Kanai, Takanori, Dang, Shuangsuo, Li, Zongfang, Dufour, Jean-François, Zoulim, Fabien, Andreone, Pietro, Cheung, Ramsey C., Tanaka, Yasuhito, Furusyo, Norihiro, Toyoda, Hidenori, Tamori, Akihiro, and Nguyen, Mindie H.

Published
2019
Full Text
View/download PDF

11. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

Author

Wong, Yu Jun, primary, Nguyen, Vy H, additional, Yang, Hwai-I, additional, Li, Jie, additional, Le, Michael Huan, additional, Wu, Wan-Jung, additional, Han, Nicole, additional, Fong, Khi Yung, additional, Chen, Elizabeth, additional, Wong, Connie, additional, Rui, Fajuan, additional, Xu, Xiaoming, additional, Xue, Qi, additional, Hu, Xin Yu, additional, Leow, Wei Qiang, additional, George Goh, Boon Bee, additional, Cheung, Ramsey C., additional, Wong, Grace, additional, Wong, Vincent Wai-Sun, additional, Yu, Ming-Whei, additional, and Nguyen, Mindie, additional

Published
2023
Full Text
View/download PDF

14. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients

Author

Yeo, Yee Hui, Tseng, Tai-Chung, Hosaka, Tetsuya, Cunningham, Chris, Fung, James Yan Yue, Ho, Hsiu J., Kwak, Min-Sun, Trinh, Huy N., Ungtrakul, Teerapat, Yu, Ming-Lung, Kobayashi, Mariko, Le, An K., Henry, Linda, Li, Jiayi, Zhang, Jian, Sriprayoon, Tassanee, Jeong, Donghak, Tanwandee, Tawesak, Gane, Ed, Cheung, Ramsey C., Wu, Chun-Ying, Lok, Anna S., Lee, Hyo-Suk, Suzuki, Fumitaka, Yuen, Man-Fung, Kao, Jia-Horng, Yang, Hwai-I, and Nguyen, Mindie H.

Published
2020
Full Text
View/download PDF

15. Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study

Author

Ogawa, Eiichi, primary, Jun, Dae Won, additional, Toyoda, Hidenori, additional, Hsu, Yao-Chun, additional, Yoon, Eileen, additional, Ahn, Sang Bong, additional, Do, Son, additional, Trinh, Huy, additional, Takahashi, Hirokazu, additional, Enomoto, Masaru, additional, Yasuda, Satoshi, additional, Tseng, Cheng-Hao, additional, Yeh, Ming-Lun, additional, Kawashima, Keigo, additional, Lee, Han Ah, additional, Inoue, Kaori, additional, Haga, Hiroaki, additional, Do, Ai-Thien, additional, Maeda, Mayumi, additional, Hoang, Joseph, additional, Cheung, Ramsey C., additional, Ueno, Yoshiyuki, additional, Eguchi, Yuichiro, additional, Furusyo, Norihiro, additional, Yu, Ming-Lung, additional, Tanaka, Yasuhito, additional, and Nguyen, Mindie, additional

Published
2022
Full Text
View/download PDF

22. Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis

Author

Kam, Leslie Y., primary, Huang, Daniel Q., additional, Teng, Margaret L.P., additional, Takahashi, Hirokazu, additional, Tanaka, Kenichi, additional, Yasuda, Satoshi, additional, Fung, James, additional, Lee, Teng-Yu, additional, Hyogo, Hideyuki, additional, Ono, Masafumi, additional, Saruwatari, Junji, additional, Oniki, Kentaro, additional, Yeo, Yee Hui, additional, Barnett, Scott, additional, Henry, Linda, additional, Li, Jie, additional, Zou, Biyao, additional, Cheung, Ramsey C., additional, Kumada, Takashi, additional, Yuen, Man-Fung, additional, Eguchi, Yuichiro, additional, Toyoda, Hidenori, additional, and Nguyen, Mindie H., additional

Published
2021
Full Text
View/download PDF

23. Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis.

Author

Kam, Leslie Y., Huang, Daniel Q., Teng, Margaret L.P., Takahashi, Hirokazu, Tanaka, Kenichi, Yasuda, Satoshi, Fung, James, Lee, Teng-Yu, Hyogo, Hideyuki, Ono, Masafumi, Saruwatari, Junji, Oniki, Kentaro, Yeo, Yee Hui, Barnett, Scott, Henry, Linda, Li, Jie, Zou, Biyao, Cheung, Ramsey C., Kumada, Takashi, and Yuen, Man-Fung

Subjects
NON-alcoholic fatty liver disease, FATTY liver, BODY mass index
Abstract

Introduction: NAFLD is increasingly prevalent in Asia, where people suffer more metabolic comorbidities at a lower body mass index (BMI), suggesting potential differences in their clinical profile. Therefore, we attempted to characterize the clinical profile of Asians with NAFLD via a meta-analytic approach. Methods: We searched PubMed, EMBASE, and Cochrane databases from January 1, 2000, to January 17, 2019. Two authors independently reviewed and selected 104 articles (2,247,754 persons) that identified NAFLD in Asians and reported relevant data, especially BMI and ALT, and excluded individuals with other liver disease and excessive alcohol consumption. Individual patient-level data were obtained from seven cohorts in Asia to complement meta-analyzed data. Results: Overall, the mean age was 52.07 (95% CI: 51.28–52.85) years, with those from Southeast Asia (42.66, 95% CI: 32.23–53.11) being significantly younger. The mean BMI was 26.2 kg/m2, higher in moderate-severe versus mild hepatic steatosis (28.3 vs. 25.7) patients and NFS ≥ −1.455 versus <−1.455 (27.09 vs. 26.02), with 34% having nonobese NAFLD. The mean ALT was 31.74 U/L, higher in NFS < −1.455 versus ≥−1.455 (33.74 vs. 27.83), though no differences were found by obesity or steatosis severity. The majority of males (85.7%) and females (60.7%) had normal to minimally elevated ALT (1–1.5 × 95% ULN). Individual patient-level data analysis (N = 7,668) demonstrated similar results. Conclusion: About one-third of Asians with NAFLD were nonobese, and the majority did not have markedly elevated ALT. Therefore, abnormal ALT or BMI is not recommended as a criterion for NAFLD screening in this population. Additionally, there were significant differences in the clinical profiles of NAFLD among the different regions of Asia. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

29. Differential characteristics and outcomes of Asian and non‐Asian patients with HBV‐related hepatocellular carcinoma

Author

Huang, Daniel Q., primary, Hoang, Joseph K., additional, Leong, Jennifer, additional, Riveiro‐Barciela, Mar, additional, Maeda, Mayumi, additional, Yang, Ju Dong, additional, Accarino, Elena Vargas, additional, Thin, Khin, additional, Trinh, Lindsey, additional, Cheung, Ramsey C., additional, Roberts, Lewis R., additional, Buti, Maria, additional, Schwartz, Myron, additional, and Nguyen, Mindie H., additional

Published
2021
Full Text
View/download PDF

32. WED-165 - Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

Author

Wong, Yu Jun, Nguyen, Vy H, Yang, Hwai-I, Li, Jie, Le, Michael Huan, Wu, Wan-Jung, Han, Nicole, Fong, Khi Yung, Chen, Elizabeth, Wong, Connie, Rui, Fajuan, Xu, Xiaoming, Xue, Qi, Hu, Xin Yu, Leow, Wei Qiang, George Goh, Boon Bee, Cheung, Ramsey C., Wong, Grace, Wong, Vincent Wai-Sun, Yu, Ming-Whei, and Nguyen, Mindie

Published
2023
Full Text
View/download PDF

35. NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea

Author

Park, Jiyoon, primary, Lee, Eunice Yewon, additional, Li, Jie, additional, Jun, Mi Jung, additional, Yoon, Eileen, additional, Ahn, Sang Bong, additional, Liu, Chuanli, additional, Yang, Hongli, additional, Rui, Fajuan, additional, Zou, Biyao, additional, Henry, Linda, additional, Lee, Dong Hyun, additional, Jun, Dae Won, additional, Cheung, Ramsey C., additional, and Nguyen, Mindie H., additional

Published
2021
Full Text
View/download PDF

49. Hepatitis G virus: is it a hepatitis virus?

Author

Cheung, Ramsey C., Keeffe, Emmet B., and Greenberg, Harry B.

Subjects
Hepatitis viruses -- Physiological aspects, RNA viruses -- Physiological aspects, Health, Physiological aspects
Abstract

Hepatitis G virus (HGV) and GB virus C (GBV-C) are two newly discovered viral agents, different isolates of a positive-sense RNA virus that represents a new genus of Flaviviridae. The purpose of this review is to analyze new data that have recently been published on the epidemiology and associations between HGV and liver diseases such as posttransfusion hepatitis, acute and chronic non-A-E hepatitis, fulminant hepatitis, cryptogenic cirrhosis, and hepatocellular carcinoma. The role of HGV in coinfection with other hepatitis viruses, the response to antiviral therapy, and the impact of HGV on liver transplantation are also discussed. HGV is a transmissible blood-borne viral agent that frequently occurs as a coinfection with other hepatitis viruses due to common modes of transmission. The prevalence of HGV ranges from 0.9 to 10% among blood donors throughout the world and is found in 1.7% of volunteer blood donors in the United States. The majority of patients infected with HGV by blood transfusion do not develop chronic hepatitis, but hepatitis G viremia frequently persists without biochemical evidence of hepatitis. Serum HGV RNA has been found in 0 to 50% of patients with fulminant hepatitis of unknown etiology and 14 to 36% of patients with cryptogenic cirrhosis. The association between HGV and chronic non-A-E hepatitis remains unclear. Although HGV appears to be a hepatotrophic virus, its role in independently causing acute and chronic liver diseases remains uncertain. (Cheung RC, Keeffe EB, Greenberg HB. Hepatitis G virus: is it a hepatitis virus? West J Med 1997 July; 167:23-33), Viral hepatitis is a major problem worldwide and is caused by five well-characterized etiologic agents.(*) Hepatitis viruses A, B, C, D, and E are distinct viruses whose molecular structure and [...]

Published
1997

Catalog

Books, media, physical & digital resources
See catalog results